Literature DB >> 6416141

[18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures.

W H Theodore, M E Newmark, S Sato, R Brooks, N Patronas, R De La Paz, G DiChiro, R M Kessler, R Margolin, R G Manning.   

Abstract

Positron emission tomography with simultaneous electroencephalographic monitoring was performed with [18F]fluorodeoxyglucose in 20 patients with complex partial seizures who had normal computed tomographic scans. Seven patients had only unilateral epileptiform discharges on the electroencephalogram, 3 had predominantly unilateral discharges, and 10 had nonlocalized epileptiform abnormalities. Positron emission tomography showed a hypometabolic lesion in 16 of the 20 patients. Pathological changes in the hypometabolic region were found in postoperative specimens in 4 of 5 patients studied. Positron emission tomography was unaffected by the seizure frequency, state of alertness, or number of spike discharges during the scan. There was a tendency for patients to have higher overall metabolic rates when taking less medication. Seizures occurring during [18F]fluorodeoxyglucose uptake in 3 patients produced a hypermetabolic area at the interictal hypometabolic focus. Positron emission tomography sometimes showed more widespread hypometabolism than suspected on the basis of the scalp-recorded electroencephalogram. The frontal lobe showed a greater degree of hypometabolism than the temporal lobe in 3 patients. Focal lesions may be identified by positron emission tomography even if the electroencephalographic abnormality is not well localized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416141     DOI: 10.1002/ana.410140406

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

3.  The new FDG brain revolution: the neurovascular unit and the default network.

Authors:  Stelvio Sestini; Antonio Castagnoli; Luigi Mansi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05       Impact factor: 9.236

4.  CT, MRI, and PET in a case of intractable epilepsy.

Authors:  L Metsähonkala; T Aärimaa; P Sonninen; H Mikola; U Ruotsalainen; J Bergman
Journal:  Childs Nerv Syst       Date:  1996-07       Impact factor: 1.475

5.  Single photon emission computed tomography with 99mTc HM-PAO in the study of focal epilepsy.

Authors:  E Grasso; L Ambrogio; A Cognazzo; P C Gerbino-Promis; P Zagnoni; G F Camuzzini; A Papaleo; F Acchiardi; G Perno
Journal:  Ital J Neurol Sci       Date:  1989-04

Review 6.  Imaging the head: functional imaging.

Authors:  G V Sawle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

7.  Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy.

Authors:  Young-Min Lim; Yong-Won Cho; Sadat Shamim; Jeffrey Solomon; Rasmus Birn; Wen Ming Luh; William D Gaillard; Eva K Ritzl; William H Theodore
Journal:  Epilepsy Res       Date:  2008-12       Impact factor: 3.045

8.  Correlations between cerebral blood flow variations and clinical parameters in temporal lobe epilepsy: an interictal study.

Authors:  J Valmier; J Touchon; P Daures; M Zanca; M Baldy-Moulinier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

9.  Brain SPECT imaging in temporal lobe epilepsy.

Authors:  Y Krausz; D Cohen; S Konstantini; Z Meiner; S Yaffe; H Atlan
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 10.  How to establish causality in epilepsy surgery.

Authors:  Eishi Asano; Erik C Brown; Csaba Juhász
Journal:  Brain Dev       Date:  2013-05-15       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.